News
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning applies to males ages 16 to 25 and is based on new data from FDA safety monitoring and a 2023 study. This includes both Pfizer's Comirnaty and Moderna's Spikevax vaccines.
FDA asks mRNA vaccine makers to widen age range for rare heart risk warning
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA vaccines to widen the age range of boys and young men that their labels say are at risk for a rare side effect causing heart inflammation.
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
Advisers to the FDA will debate if the virus has mutated enough since last winter to require a tweak to the formula.
Moderna has withdrawn the Biologics License Application (BLA) for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback